Treatment options, ranging from corticosteroids and intravenous immunoglobulin to thrombopoietin receptor agonists and immunosuppressive agents, must be selected based on the severity of thrombocytopenia and the stage of pregnancy. This evidence concerns the gene MPL and Thrombocytopenia.